Hou, H., Tsai, C., Lin, C., Chou, W., Kuo, Y., Liu, C., . . . Tien, H. (2018). Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome. Blood Cancer J.
シカゴスタイル引用形Hou, Hsin-An, et al. "Incorporation of Mutations in Five Genes in the Revised International Prognostic Scoring System Can Improve Risk Stratification in the Patients With Myelodysplastic Syndrome." Blood Cancer J 2018.
MLA引用形式Hou, Hsin-An, et al. "Incorporation of Mutations in Five Genes in the Revised International Prognostic Scoring System Can Improve Risk Stratification in the Patients With Myelodysplastic Syndrome." Blood Cancer J 2018.
警告: この引用は必ずしも正確ではありません.